Viewing Study NCT02143635

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:03 PM
Ignite Modification Date: 2026-01-31 @ 12:55 PM
Study NCT ID: NCT02143635
Status: COMPLETED
Last Update Posted: 2021-05-21
First Post: 2014-05-19
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study to Determine and Evaluate a Safe and Tolerated Dose of HDM201 in Patients With Selected Advanced Tumors That Are TP53wt
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid and Hematological TP53wt Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HDM201,TP53wt, p53, MDM2, HDM2, advanced tumors, BLRM (Bayesian logistic regression … View